一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Free Radical Biology and Medicine >>article
Free Radical Biology and Medicine

Free Radical Biology and Medicine

IF: 7.1
Download PDF

Epimedokoreanin B blocks autophagic flux to inhibit progression of triple negative breast cancer through targeting MCOLN1/TRPML1 channel

Published:20 August 2025 DOI: 10.1016/j.freeradbiomed.2025.08.041
Chenyang Zhao , Peng Zhang , Xiaojuan Yang , Miao Liu , Zhirong Guan , Bin Ma , Xiangguo Duan , Chunxia Su

Abstract

Triple-negative breast cancer (TNBC) remains a highly malignant subtype with limited therapeutic options. Here, Epimedokoreanin B (EKB), a flavonoid derived from Epimedium brevicornum, is identified as a potent inhibitor of TNBC progression. Mechanistically, EKB directly binds MCOLN1/TRPML1, thereby promoting lysosomal Ca2+ efflux and impairing lysosomal acidification. This disruption specifically blocks autophagosome-lysosome fusion, leading to autophagic flux inhibition and subsequent accumulation of intracellular oxidants, including hydrogen peroxide (H2O2), related peroxides, and mitochondrial superoxide (O2?-). Importantly, the resulting oxidative stress acts as a critical mediator, ultimately triggering apoptosis. The specificity of the EKB-MCOLN1/TRPML1 interaction was validated through molecular docking, Cellular Thermal Shift Assay (CETSA), and pharmacological MCOLN1/TRPML1inhibition. In TNBC mouse models, EKB treatment significantly suppressed primary tumor growth and, notably, reduced pulmonary metastasis. Additionally, no systemic toxicity was observed. Furthermore, EKB treatment reprogrammed the tumor immune microenvironment, evidenced by increased infiltration of CD8+T cells and M1 macrophages alongside reduced immunosuppressive subsets. Taken together, these results establish EKB as a promising therapeutic candidate that couples autophagy blockade with immune activation, and highlight oxidative stress as a significant contributing mechanism underlying its anticancer effects.

Substances (26)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Rapamycin 53123-88-9 C51H79NO13 1033 suppliers $9.00-$6160.00
Rapamycin 53123-88-9 C51H79NO13 1033 suppliers $9.00-$6160.00
Rapamycin 53123-88-9 C51H79NO13 1033 suppliers $9.00-$6160.00
Rapamycin 53123-88-9 C51H79NO13 1033 suppliers $9.00-$6160.00
BAPTA 85233-19-8 C22H24N2O10 216 suppliers $8.00-$3850.00
BAPTA 85233-19-8 C22H24N2O10 216 suppliers $8.00-$3850.00
BAPTA 85233-19-8 C22H24N2O10 216 suppliers $8.00-$3850.00
BAPTA 85233-19-8 C22H24N2O10 216 suppliers $8.00-$3850.00
TPEN 16858-02-9 C26H28N6 195 suppliers $9.00-$4200.00
TPEN 16858-02-9 C26H28N6 195 suppliers $9.00-$4200.00

Similar articles

IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
IF:6.9

Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene.

Biomedicine & Pharmacotherapy Mehdi Roshanian Bakhsh, Leila Rouhi,etc Published: 1 August 2023
IF:10.5

Self-assembling mertansine prodrug improves tolerability and efficacy of chemotherapy against metastatic triple-negative breast cancer

Journal of Controlled Release Wei Ran , Xiaoyu Liu ,etc Published: 1 February 2020
沙坪坝区| 务川| 大同市| 永登县| 明水县| 阜平县| 永登县| 大新县| 琼中| 万州区| 凉城县| 桂阳县| 武安市| 新干县| 比如县| 镇巴县| 若羌县| 碌曲县| 德昌县| 县级市| 洪江市| 光泽县| 乌拉特前旗| 永寿县| 汉中市| 长宁区| 巴林左旗| 峡江县| 民丰县| 嘉禾县| 拜泉县| 布尔津县| 鹤峰县| 黎城县| 永修县| 囊谦县| 佳木斯市| 柳州市| 海原县| 左云县| 乌拉特中旗|